159 related articles for article (PubMed ID: 35787702)
21. Benefits and limitations of middle bile duct segmental resection for extrahepatic cholangiocarcinoma.
Akita M; Ajiki T; Ueno K; Tsugawa D; Tanaka M; Kido M; Toyama H; Fukumoto T
Hepatobiliary Pancreat Dis Int; 2020 Apr; 19(2):147-152. PubMed ID: 32037277
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of lymphadenectomy for long-term outcomes in node-negative intrahepatic cholangiocarcinoma: A multicenter study.
Yoh T; Cauchy F; Le Roy B; Seo S; Taura K; Hobeika C; Dokmak S; Farges O; Gelli M; Sa Cunha A; Adam R; Uemoto S; Soubrane O
Surgery; 2019 Dec; 166(6):975-982. PubMed ID: 31421869
[TBL] [Abstract][Full Text] [Related]
23. [A case of postoperative recurrent hilar cholangiocarcinoma in the lower bile duct treated with pancreatoduodenectomy].
Kawahara R; Tanigawa M; Horiuchi H; Takahashi K; Shirahama T; Nakama Y; Takagi H; Hirakawa Y; Maruyama Y; Sakai H; Ishikawa H; Hisaka T; Yasunaga M; Okuda K
Gan To Kagaku Ryoho; 2014 Nov; 41(12):1518-20. PubMed ID: 25731238
[TBL] [Abstract][Full Text] [Related]
24. Long-term outcome after surgical resection for cholangiocarcinoma and prognostic index value.
Wang Y; Duan B; Yan L; Shen C; Wu B; Luo J; Shen F; Zhao G
Surgeon; 2016 Feb; 14(1):38-43. PubMed ID: 25263386
[TBL] [Abstract][Full Text] [Related]
25. The clinical and prognostic factors for biliary neuroendocrine neoplasm: a study based on the SEER database.
Zheng BH; Zhang C; Wan WZ; Sun WT; Cheng X; Ni XJ; Ni XL; Suo T; Liu H; Shen S; Liu HB
BMC Surg; 2022 Jun; 22(1):253. PubMed ID: 35768809
[TBL] [Abstract][Full Text] [Related]
26. Adjuvant concurrent chemoradiation for adenocarcinoma of the distal common bile duct.
Hughes MA; Frassica DA; Yeo CJ; Riall TS; Lillemoe KD; Cameron JL; Donehower RC; Laheru DA; Hruban RH; Abrams RA
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):178-82. PubMed ID: 17276614
[TBL] [Abstract][Full Text] [Related]
27. Surgical resection of hilar cholangiocarcinoma: analysis of survival and postoperative complications.
Hasegawa S; Ikai I; Fujii H; Hatano E; Shimahara Y
World J Surg; 2007 Jun; 31(6):1256-63. PubMed ID: 17453285
[TBL] [Abstract][Full Text] [Related]
28. Single centre experience with surgical treatment of hilar cholangiocarcinoma.
Vladov N; Lukanova Ts; Takorov I; Mutafchiyski V; Vasilevski I; Sergeev S; Odisseeva E
Chirurgia (Bucur); 2013; 108(3):299-303. PubMed ID: 23790776
[TBL] [Abstract][Full Text] [Related]
29. Adequate lymph node assessment for extrahepatic bile duct adenocarcinoma.
Ito K; Ito H; Allen PJ; Gonen M; Klimstra D; D'Angelica MI; Fong Y; DeMatteo RP; Brennan MF; Blumgart LH; Jarnagin WR
Ann Surg; 2010 Apr; 251(4):675-81. PubMed ID: 20224368
[TBL] [Abstract][Full Text] [Related]
30. Comparison of pancreaticoduodenectomy and bile duct resection for middle bile duct cancer: A multi-center collaborating study of Japan and Korea.
Hayashi H; Jang JY; Kim KS; Choi JS; Takahara T; Choi SH; Hirano S; Yu HC; Uemura S; Unno M
J Hepatobiliary Pancreat Sci; 2020 Jun; 27(6):289-298. PubMed ID: 32048467
[TBL] [Abstract][Full Text] [Related]
31. Laparoscopic liver resection versus open liver resection for intrahepatic cholangiocarcinoma: 3-year outcomes of a cohort study with propensity score matching.
Kang SH; Choi Y; Lee W; Ahn S; Cho JY; Yoon YS; Han HS
Surg Oncol; 2020 Jun; 33():63-69. PubMed ID: 32561101
[TBL] [Abstract][Full Text] [Related]
32. Surgical outcomes of 230 resected hilar cholangiocarcinoma in a single centre.
Song SC; Choi DW; Kow AW; Choi SH; Heo JS; Kim WS; Kim MJ
ANZ J Surg; 2013 Apr; 83(4):268-74. PubMed ID: 22943422
[TBL] [Abstract][Full Text] [Related]
33. Impact of adjuvant chemotherapy after pancreaticoduodenectomy for distal cholangiocarcinoma: a propensity score analysis from a French multicentric cohort.
Bergeat D; Turrini O; Courtin-Tanguy L; Truant S; Darnis B; Delpero JR; Mabrut JY; Regenet N; Sulpice L
Langenbecks Arch Surg; 2018 Sep; 403(6):701-709. PubMed ID: 30112638
[TBL] [Abstract][Full Text] [Related]
34. Surgery for hilar cholangiocarcinoma; a 10 year experience of a tertiary referral centre in the UK.
Silva MA; Tekin K; Aytekin F; Bramhall SR; Buckels JA; Mirza DF
Eur J Surg Oncol; 2005 Jun; 31(5):533-9. PubMed ID: 15922889
[TBL] [Abstract][Full Text] [Related]
35. Clinical Characteristics and Prognostic Factors of Patients with Intrahepatic Cholangiocarcinoma with Fever: A Propensity Score Matching Analysis.
Gong ZJ; Cheng JW; Gao PT; Huang A; Sun YF; Zhou KQ; Hu B; Qiu SJ; Zhou J; Fan J; Yang XR
Oncologist; 2019 Jul; 24(7):997-1007. PubMed ID: 30910867
[TBL] [Abstract][Full Text] [Related]
36. Surgical management of cholangiocarcinoma.
Jarnagin WR; Shoup M
Semin Liver Dis; 2004 May; 24(2):189-99. PubMed ID: 15192791
[TBL] [Abstract][Full Text] [Related]
37. Surgical outcome and prognostic factors in intrahepatic cholangiocarcinoma.
Nakagohri T; Kinoshita T; Konishi M; Takahashi S; Gotohda N
World J Surg; 2008 Dec; 32(12):2675-80. PubMed ID: 18843437
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of positive surgical margins after resection of cholangiocarcinoma. Experience at a high-volume hospital center specializing in hepatopancreatobiliary surgery.
Morales-Cruz M; Armillas-Canseco F; Carpinteyro-Espín P; Domínguez-Rosado I; Mercado MA
Rev Gastroenterol Mex (Engl Ed); 2020; 85(1):18-24. PubMed ID: 31685297
[TBL] [Abstract][Full Text] [Related]
39. The impact of liver resection on survival for locally advanced intrahepatic cholangiocarcinoma tumors: A propensity score analysis.
Moustafa M; Fasolo E; Bassi D; D'amico FE; Gringeri E; Pawlik TM; Cillo U
Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):632-637. PubMed ID: 31812289
[TBL] [Abstract][Full Text] [Related]
40. Histologic bile duct invasion by a mass-forming intrahepatic cholangiocarcinoma.
Hirohashi K; Uenishi T; Kubo S; Yamamoto T; Tanaka H; Shuto T; Yamasaki O; Horii K; Kinoshita H
J Hepatobiliary Pancreat Surg; 2002; 9(2):233-6. PubMed ID: 12140612
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
